Table 1 Baseline clinical characteristics of patients stratified by the optimal cutoff point of the TyG index
|  | Total population (n = 317) | Lower TyG index (≤ 8.47, n = 168) | Higher TyG index (> 8.47, n = 149) | p value |
|---|---|---|---|---|
TyG index | 8.52 ± 0.62 | 8.06 ± 0.30 | 9.03 ± 0.47 |  < 0.001 |
Age | 67.70 ± 12.31 | 67.97 ± 12.92 | 67.40 ± 11.62 | 0.683 |
Sex | ||||
  Female | 118 (37.2) | 63 (37.5) | 55 (36.9) | 1.000 |
  Male | 199 (62.8) | 105 (62.5) | 94 (63.1) |  |
FPG, mmol/L | 5.71 ± 2.49 | 4.87 ± 1.03 | 6.65 ± 3.21 |  < 0.001 |
Total Cholesterol, mmol/L | 4.51 ± 1.21 | 4.27 ± 1.0 | 4.79 ± 1.30 |  < 0.001 |
TG, mmol/L | 1.34 ± 0.83 | 0.87 ± 0.23 | 1.86 ± 0.94 |  < 0.001 |
LDL-C, mmol/L | 2.83 ± 0.87 | 2.63 ± 0.76 | 3.05 ± 0.92 |  < 0.001 |
HDL-C, mmol/L | 1.14 ± 0.34 | 1.20 ± 0.34 | 1.07 ± 0.32 | 0.001 |
SBP, mmHg | 132.11 ± 21.59 | 130.62 ± 21.15 | 133.80 ± 22.03 | 0.191 |
DBP, mmHg | 72.38 ± 12.95 | 70.30 ± 12.54 | 74.73 ± 13.04 | 0.002 |
BMI, kg/m2 | 23.23 ± 3.66 | 22.29 ± 3.47 | 24.28 ± 3.59 |  < 0.001 |
Smoking | 96 (30.3) | 48 (28.6) | 48 (32.2) | 0.560 |
Drinking | 59 (18.6) | 24 (14.3) | 35 (23.5) | 0.050 |
Hypertension | 171 (53.9) | 86 (51.2) | 85 (57.0) | 0.352 |
Diabetes mellitus | 64 (20.2) | 21 (12.5) | 43 (28.9) |  < 0.001 |
CHD | 108 (34.1) | 49 (29.2) | 59 (39.6) | 0.066 |
Stroke | 29 (9.1) | 16 (9.5) | 13 (8.7) | 0.959 |
Statins | 151 (47.6) | 76 (45.2) | 75 (50.3) | 0.427 |
Hypoglycemic medications | ||||
  Oral hypoglycemic agents | 48 (15.1) | 14 (8.3) | 34 (22.8) | 0.001 |
  Insulin | 36 (11.4) | 10 (6.0) | 26 (17.4) | 0.002 |
Antihypertension medication | 230 (72.6) | 118 (70.2) | 112 (75.2) | 0.392 |
Antiplatelets | 142 (44.8) | 71 (42.3) | 71 (47.7) | 0.395 |
Aortic valve replacement | 144 (45.4) | 75 (44.6) | 69 (46.3) | 0.854 |
Aortic stenosis severity | ||||
  Moderate | 94 (29.7) | 50 (29.8) | 44 (29.5) | 1.000 |
 Severe | 223 (70.3) | 118 (70.2) | 105 (70.5) |  |